25 XP   0   0   10

Sichuan Kelun Pharmaceutical Co Ltd
Buy, Hold or Sell?

Let's analyse Kelun together

PenkeI guess you are interested in Sichuan Kelun Pharmaceutical Co Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Sichuan Kelun Pharmaceutical Co Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Sichuan Kelun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Sichuan Kelun Pharmaceutical Co Ltd.

Quick analysis of Kelun (30 sec.)










What can you expect buying and holding a share of Kelun? (30 sec.)

How much money do you get?

How much money do you get?
¥0.36
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥10.54
Expected worth in 1 year
¥17.43
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥9.47
Return On Investment
29.2%

For what price can you sell your share?

Current Price per Share
¥32.40
Expected price per share
¥30.83 - ¥33.28
How sure are you?
50%

1. Valuation of Kelun (5 min.)




Live pricePrice per Share (EOD)

¥32.40

Intrinsic Value Per Share

¥10.93 - ¥23.60

Total Value Per Share

¥21.48 - ¥34.15

2. Growth of Kelun (5 min.)




Is Kelun growing?

Current yearPrevious yearGrowGrow %
How rich?$2.3b$1.9b$380.6m16.3%

How much money is Kelun making?

Current yearPrevious yearGrowGrow %
Making money$235.8m$152.1m$83.6m35.5%
Net Profit Margin9.0%6.4%--

How much money comes from the company's main activities?

3. Financial Health of Kelun (5 min.)




What can you expect buying and holding a share of Kelun? (5 min.)

Welcome investor! Kelun's management wants to use your money to grow the business. In return you get a share of Kelun.

What can you expect buying and holding a share of Kelun?

First you should know what it really means to hold a share of Kelun. And how you can make/lose money.

Speculation

The Price per Share of Kelun is ¥32.40. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Kelun.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Kelun, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥10.54. Based on the TTM, the Book Value Change Per Share is ¥1.72 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.08 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.65 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Kelun.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.150.5%0.150.5%0.100.3%0.100.3%0.080.3%
Usd Book Value Change Per Share0.240.7%0.240.7%0.010.0%0.080.3%0.070.2%
Usd Dividend Per Share0.090.3%0.090.3%0.090.3%0.090.3%0.070.2%
Usd Total Gains Per Share0.331.0%0.331.0%0.100.3%0.170.5%0.140.4%
Usd Price Per Share3.67-3.67-2.61-3.01-3.37-
Price to Earnings Ratio24.94-24.94-27.50-31.47-41.58-
Price-to-Total Gains Ratio11.24-11.24-27.02-20.28-28.35-
Price to Book Ratio2.52-2.52-2.15-2.43-3.20-
Price-to-Total Gains Ratio11.24-11.24-27.02-20.28-28.35-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.4712
Number of shares223
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.090.09
Usd Book Value Change Per Share0.240.08
Usd Total Gains Per Share0.330.17
Gains per Quarter (223 shares)72.8638.04
Gains per Year (223 shares)291.44152.18
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1792122817775142
2159424572154151294
3238636863230226446
43188481154307302598
539710601445384377750
647712721736461452902
7556148420275375281054
8635169623186146031206
9715190826096916791358
10794212029007687541510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%13.00.00.0100.0%

Fundamentals of Kelun

About Sichuan Kelun Pharmaceutical Co Ltd

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sichuan Kelun Industry Group CO., LTD.

Fundamental data was last updated by Penke on 2024-04-14 16:11:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is underpriced.

1.1. Profitability of Sichuan Kelun Pharmaceutical Co Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Kelun earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • A Net Profit Margin of 9.0% means that ¥0.09 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 9.0%. The company is making a profit. +1
  • The TTM is 9.0%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ9.0%TTM9.0%0.0%
TTM9.0%YOY6.4%+2.7%
TTM9.0%5Y6.6%+2.4%
5Y6.6%10Y8.3%-1.7%
1.1.2. Return on Assets

Shows how efficient Kelun is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • 5.0% Return on Assets means that Kelun generated ¥0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 5.0%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 5.0%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ5.0%TTM5.0%0.0%
TTM5.0%YOY3.5%+1.5%
TTM5.0%5Y3.6%+1.4%
5Y3.6%10Y3.7%-0.1%
1.1.3. Return on Equity

Shows how efficient Kelun is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • 10.8% Return on Equity means Kelun generated ¥0.11 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 10.8%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 10.8%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ10.8%TTM10.8%0.0%
TTM10.8%YOY8.0%+2.9%
TTM10.8%5Y8.3%+2.5%
5Y8.3%10Y7.9%+0.4%

1.2. Operating Efficiency of Sichuan Kelun Pharmaceutical Co Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Kelun is operating .

  • Measures how much profit Kelun makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • An Operating Margin of 12.0% means the company generated ¥0.12  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 12.0%. The company is operating less efficient.
  • The TTM is 12.0%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ12.0%TTM12.0%0.0%
TTM12.0%YOY8.6%+3.4%
TTM12.0%5Y9.8%+2.2%
5Y9.8%10Y9.2%+0.6%
1.2.2. Operating Ratio

Measures how efficient Kelun is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • An Operation Ratio of 1.34 means that the operating costs are ¥1.34 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 1.340. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.340. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.340TTM1.3400.000
TTM1.340YOY1.344-0.005
TTM1.3405Y1.324+0.015
5Y1.32410Y1.192+0.132

1.3. Liquidity of Sichuan Kelun Pharmaceutical Co Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Kelun is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A Current Ratio of 1.38 means the company has ¥1.38 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 1.381. The company is just able to pay all its short-term debts.
  • The TTM is 1.381. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.381TTM1.3810.000
TTM1.381YOY1.045+0.336
TTM1.3815Y1.160+0.221
5Y1.16010Y0.882+0.277
1.3.2. Quick Ratio

Measures if Kelun is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • A Quick Ratio of 0.51 means the company can pay off ¥0.51 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 0.510. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.510. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.510TTM0.5100.000
TTM0.510YOY0.525-0.015
TTM0.5105Y0.546-0.036
5Y0.54610Y0.604-0.058

1.4. Solvency of Sichuan Kelun Pharmaceutical Co Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Kelun assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Kelun to Drug Manufacturers - General industry mean.
  • A Debt to Asset Ratio of 0.51 means that Kelun assets are financed with 50.5% credit (debt) and the remaining percentage (100% - 50.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 0.505. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.505. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.505TTM0.5050.000
TTM0.505YOY0.552-0.047
TTM0.5055Y0.547-0.042
5Y0.54710Y0.525+0.022
1.4.2. Debt to Equity Ratio

Measures if Kelun is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Kelun to the Drug Manufacturers - General industry mean.
  • A Debt to Equity ratio of 109.4% means that company has ¥1.09 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The MRQ is 1.094. The company is able to pay all its debts with equity. +1
  • The TTM is 1.094. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.094TTM1.0940.000
TTM1.094YOY1.256-0.163
TTM1.0945Y1.260-0.166
5Y1.26010Y1.151+0.109

2. Market Valuation of Sichuan Kelun Pharmaceutical Co Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Kelun generates.

  • Above 15 is considered overpriced but always compare Kelun to the Drug Manufacturers - General industry mean.
  • A PE ratio of 24.94 means the investor is paying ¥24.94 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The EOD is 30.369. Based on the earnings, the company is overpriced. -1
  • The MRQ is 24.942. Based on the earnings, the company is fair priced.
  • The TTM is 24.942. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD30.369MRQ24.942+5.427
MRQ24.942TTM24.9420.000
TTM24.942YOY27.498-2.556
TTM24.9425Y31.472-6.530
5Y31.47210Y41.585-10.112
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The EOD is 23.255. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The MRQ is 19.099. Based on how much money comes from the company's main activities, the company is underpriced. +1
  • The TTM is 19.099. Based on how much money comes from the company's main activities, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD23.255MRQ19.099+4.156
MRQ19.099TTM19.0990.000
TTM19.099YOY16.330+2.769
TTM19.0995Y25.953-6.854
5Y25.95310Y-4.498+30.451
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Kelun is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - General industry mean).
  • A PB ratio of 2.52 means the investor is paying ¥2.52 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Sichuan Kelun Pharmaceutical Co Ltd:

  • The EOD is 3.073. Based on the equity, the company is fair priced.
  • The MRQ is 2.524. Based on the equity, the company is underpriced. +1
  • The TTM is 2.524. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD3.073MRQ2.524+0.549
MRQ2.524TTM2.5240.000
TTM2.524YOY2.146+0.378
TTM2.5245Y2.430+0.094
5Y2.43010Y3.200-0.770
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Sichuan Kelun Pharmaceutical Co Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--1.7221.7220%0.079+2085%0.613+181%0.489+253%
Book Value Per Share--10.54410.5440%8.822+20%8.977+17%7.961+32%
Current Ratio--1.3811.3810%1.045+32%1.160+19%0.882+57%
Debt To Asset Ratio--0.5050.5050%0.552-9%0.547-8%0.525-4%
Debt To Equity Ratio--1.0941.0940%1.256-13%1.260-13%1.151-5%
Dividend Per Share--0.6450.6450%0.622+4%0.624+3%0.493+31%
Eps--1.0671.0670%0.688+55%0.723+48%0.615+73%
Free Cash Flow Per Share--1.3931.3930%1.159+20%0.947+47%0.263+429%
Free Cash Flow To Equity Per Share--1.3931.3930%0.366+281%0.468+198%0.259+437%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--23.605--------
Intrinsic Value_10Y_min--10.931--------
Intrinsic Value_1Y_max--1.342--------
Intrinsic Value_1Y_min--0.478--------
Intrinsic Value_3Y_max--4.812--------
Intrinsic Value_3Y_min--1.979--------
Intrinsic Value_5Y_max--9.222--------
Intrinsic Value_5Y_min--4.065--------
Market Cap51891516518.400+18%42618310325.76042618310325.7600%30318099002.880+41%34953100509.184+22%39056406161.976+9%
Net Profit Margin--0.0900.0900%0.064+42%0.066+36%0.083+8%
Operating Margin--0.1200.1200%0.086+39%0.098+23%0.092+30%
Operating Ratio--1.3401.3400%1.3440%1.324+1%1.192+12%
Pb Ratio3.073+18%2.5242.5240%2.146+18%2.430+4%3.200-21%
Pe Ratio30.369+18%24.94224.9420%27.498-9%31.472-21%41.585-40%
Price Per Share32.400+18%26.61026.6100%18.930+41%21.824+22%24.386+9%
Price To Free Cash Flow Ratio23.255+18%19.09919.0990%16.330+17%25.953-26%-4.498+124%
Price To Total Gains Ratio13.685+18%11.23911.2390%27.017-58%20.284-45%28.351-60%
Quick Ratio--0.5100.5100%0.525-3%0.546-7%0.604-16%
Return On Assets--0.0500.0500%0.035+43%0.036+38%0.037+35%
Return On Equity--0.1080.1080%0.080+36%0.083+30%0.079+37%
Total Gains Per Share--2.3682.3680%0.701+238%1.236+92%0.981+141%
Usd Book Value--2330539275.5702330539275.5700%1949863391.508+20%1984184481.270+17%1759468054.421+32%
Usd Book Value Change Per Share--0.2380.2380%0.011+2085%0.085+181%0.067+253%
Usd Book Value Per Share--1.4551.4550%1.217+20%1.239+17%1.099+32%
Usd Dividend Per Share--0.0890.0890%0.086+4%0.086+3%0.068+31%
Usd Eps--0.1470.1470%0.095+55%0.100+48%0.085+73%
Usd Free Cash Flow--307938077.196307938077.1960%256204511.478+20%209387802.988+47%58232309.714+429%
Usd Free Cash Flow Per Share--0.1920.1920%0.160+20%0.131+47%0.036+429%
Usd Free Cash Flow To Equity Per Share--0.1920.1920%0.050+281%0.065+198%0.036+437%
Usd Market Cap7161029279.539+18%5881326824.9555881326824.9550%4183897662.397+41%4823527870.267+22%5389784050.353+9%
Usd Price Per Share4.471+18%3.6723.6720%2.612+41%3.012+22%3.365+9%
Usd Profit--235800947.208235800947.2080%152152500.024+55%159843815.125+48%135948242.441+73%
Usd Revenue--2609946177.8942609946177.8940%2384282239.554+9%2391328019.746+9%1782721298.557+46%
Usd Total Gains Per Share--0.3270.3270%0.097+238%0.171+92%0.135+141%
 EOD+4 -4MRQTTM+0 -0YOY+30 -55Y+30 -510Y+30 -5

3.2. Fundamental Score

Let's check the fundamental score of Sichuan Kelun Pharmaceutical Co Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1530.369
Price to Book Ratio (EOD)Between0-13.073
Net Profit Margin (MRQ)Greater than00.090
Operating Margin (MRQ)Greater than00.120
Quick Ratio (MRQ)Greater than10.510
Current Ratio (MRQ)Greater than11.381
Debt to Asset Ratio (MRQ)Less than10.505
Debt to Equity Ratio (MRQ)Less than11.094
Return on Equity (MRQ)Greater than0.150.108
Return on Assets (MRQ)Greater than0.050.050
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Sichuan Kelun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.045
Ma 20Greater thanMa 5030.066
Ma 50Greater thanMa 10028.850
Ma 100Greater thanMa 20027.948
OpenGreater thanClose31.210
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets34,118,380
Total Liabilities17,230,414
Total Stockholder Equity15,751,236
 As reported
Total Liabilities 17,230,414
Total Stockholder Equity+ 15,751,236
Total Assets = 34,118,380

Assets

Total Assets34,118,380
Total Current Assets16,600,981
Long-term Assets17,517,399
Total Current Assets
Cash And Cash Equivalents 4,725,303
Short-term Investments 448,108
Net Receivables 5,682,373
Inventory 3,190,698
Other Current Assets 369,726
Total Current Assets  (as reported)16,600,981
Total Current Assets  (calculated)14,416,208
+/- 2,184,773
Long-term Assets
Property Plant Equipment 11,301,661
Goodwill 98,660
Intangible Assets 1,359,181
Other Assets 1,108,210
Long-term Assets  (as reported)17,517,399
Long-term Assets  (calculated)13,867,712
+/- 3,649,687

Liabilities & Shareholders' Equity

Total Current Liabilities12,022,370
Long-term Liabilities5,208,044
Total Stockholder Equity15,751,236
Total Current Liabilities
Short Long Term Debt 3,290,695
Accounts payable 2,216,118
Other Current Liabilities 1,309,331
Total Current Liabilities  (as reported)12,022,370
Total Current Liabilities  (calculated)6,816,144
+/- 5,206,227
Long-term Liabilities
Long term Debt 4,704,388
Capital Lease Obligations Min Short Term Debt29,041
Deferred Long Term Liability 225,802
Long-term Liabilities  (as reported)5,208,044
Long-term Liabilities  (calculated)4,959,230
+/- 248,813
Total Stockholder Equity
Common Stock1,422,247
Retained Earnings 10,438,591
Other Stockholders Equity 459,824
Total Stockholder Equity (as reported)15,751,236
Total Stockholder Equity (calculated)12,320,662
+/- 3,430,573
Other
Capital Stock1,422,247
Common Stock Shares Outstanding 1,422,247
Net Debt 3,269,779
Net Invested Capital 23,746,318
Net Tangible Assets 14,451,166
Net Working Capital 4,578,610
Property Plant and Equipment Gross 11,301,661



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
8,789,900
10,465,372
14,930,778
17,946,851
21,202,835
22,583,347
23,409,879
27,988,160
29,360,883
31,485,374
31,983,346
31,539,911
34,118,380
34,118,38031,539,91131,983,34631,485,37429,360,88327,988,16023,409,87922,583,34721,202,83517,946,85114,930,77810,465,3728,789,900
   > Total Current Assets 
0
0
0
0
0
9,153,453
8,747,565
11,618,685
12,622,490
14,174,430
14,699,932
14,008,830
16,600,981
16,600,98114,008,83014,699,93214,174,43012,622,49011,618,6858,747,5659,153,45300000
       Cash And Cash Equivalents 
4,207,471
2,090,742
2,358,678
2,280,089
2,029,776
1,850,728
1,228,046
1,231,427
1,825,830
2,253,425
2,771,951
2,919,599
4,725,303
4,725,3032,919,5992,771,9512,253,4251,825,8301,231,4271,228,0461,850,7282,029,7762,280,0892,358,6782,090,7424,207,471
       Short-term Investments 
0
0
0
0
0
290,000
120,000
507,000
200,000
0
265,421
359,530
448,108
448,108359,530265,4210200,000507,000120,000290,00000000
       Net Receivables 
1,600,166
2,302,907
2,755,419
3,454,730
3,865,029
3,970,417
4,327,731
6,406,300
6,834,701
7,847,762
5,679,096
6,685,256
5,682,373
5,682,3736,685,2565,679,0967,847,7626,834,7016,406,3004,327,7313,970,4173,865,0293,454,7302,755,4192,302,9071,600,166
       Other Current Assets 
100,745
179,623
859,865
683,942
735,861
834,980
938,629
973,474
788,526
687,015
645,296
681,399
369,726
369,726681,399645,296687,015788,526973,474938,629834,980735,861683,942859,865179,623100,745
   > Long-term Assets 
0
0
0
0
0
0
14,662,313
16,369,475
16,738,393
17,310,943
17,283,414
17,531,080
17,517,399
17,517,39917,531,08017,283,41417,310,94316,738,39316,369,47514,662,313000000
       Property Plant Equipment 
1,774,347
3,459,007
6,288,875
8,546,989
10,324,108
11,366,427
11,691,991
12,156,891
12,082,834
12,122,033
11,987,003
11,613,816
11,301,661
11,301,66111,613,81611,987,00312,122,03312,082,83412,156,89111,691,99111,366,42710,324,1088,546,9896,288,8753,459,0071,774,347
       Goodwill 
0
0
0
0
157,080
157,080
158,446
158,446
158,446
158,446
158,446
98,660
98,660
98,66098,660158,446158,446158,446158,446158,446157,080157,0800000
       Long Term Investments 
0
0
0
0
0
342,402
987,636
2,137,711
2,306,300
0
0
0
0
00002,306,3002,137,711987,636342,40200000
       Intangible Assets 
164,394
527,972
555,346
368,796
1,136,749
1,031,683
1,282,256
1,382,643
1,484,653
1,480,871
1,457,402
1,381,325
1,359,181
1,359,1811,381,3251,457,4021,480,8711,484,6531,382,6431,282,2561,031,6831,136,749368,796555,346527,972164,394
       Long-term Assets Other 
0
0
0
0
0
0
334,650
295,003
316,232
305,815
330,617
400,049
264,339
264,339400,049330,617305,815316,232295,003334,650000000
> Total Liabilities 
1,738,262
2,534,402
5,866,701
7,922,939
10,232,465
11,419,487
11,943,530
16,005,708
16,396,764
17,579,330
17,980,177
17,410,466
17,230,414
17,230,41417,410,46617,980,17717,579,33016,396,76416,005,70811,943,53011,419,48710,232,4657,922,9395,866,7012,534,4021,738,262
   > Total Current Liabilities 
1,545,163
2,170,708
2,388,505
3,275,766
5,653,876
7,700,638
10,198,469
11,891,817
10,372,387
14,820,371
12,257,778
13,408,387
12,022,370
12,022,37013,408,38712,257,77814,820,37110,372,38711,891,81710,198,4697,700,6385,653,8763,275,7662,388,5052,170,7081,545,163
       Short-term Debt 
0
0
0
0
0
2,014,545
2,820,000
2,720,000
2,650,000
0
0
0
0
00002,650,0002,720,0002,820,0002,014,54500000
       Short Long Term Debt 
0
0
0
0
0
2,014,545
2,820,000
2,720,000
2,650,000
3,175,114
4,261,338
3,367,312
3,290,695
3,290,6953,367,3124,261,3383,175,1142,650,0002,720,0002,820,0002,014,54500000
       Accounts payable 
444,139
578,424
824,531
1,345,071
1,645,929
1,467,399
1,357,752
647,641
1,549,800
876,741
1,860,887
2,155,858
2,216,118
2,216,1182,155,8581,860,887876,7411,549,800647,6411,357,7521,467,3991,645,9291,345,071824,531578,424444,139
       Other Current Liabilities 
148,868
548,949
1,060,974
778,995
481,471
155,687
251,729
1,204,340
442,455
1,174,110
597,001
1,248,717
1,309,331
1,309,3311,248,717597,0011,174,110442,4551,204,340251,729155,687481,471778,9951,060,974548,949148,868
   > Long-term Liabilities 
0
0
0
0
0
0
1,745,061
4,113,891
6,024,377
2,758,959
5,722,399
4,002,079
5,208,044
5,208,0444,002,0795,722,3992,758,9596,024,3774,113,8911,745,061000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
-2,014,545
-2,820,000
-2,720,000
-2,650,000
0
18,406
16,182
29,041
29,04116,18218,4060-2,650,000-2,720,000-2,820,000-2,014,54500000
       Long-term Liabilities Other 
0
0
0
0
0
0
21,000
3,496,459
5,449,464
2,146,557
0
0
0
0002,146,5575,449,4643,496,45921,000000000
       Deferred Long Term Liability 
0
0
0
0
0
207,036
272,848
349,058
591,553
556,220
516,117
365,278
225,802
225,802365,278516,117556,220591,553349,058272,848207,03600000
> Total Stockholder Equity
6,990,704
7,836,955
8,802,835
9,759,926
10,739,478
11,060,039
11,330,205
11,803,033
12,763,475
13,188,051
13,499,180
13,856,828
15,751,236
15,751,23613,856,82813,499,18013,188,05112,763,47511,803,03311,330,20511,060,03910,739,4789,759,9268,802,8357,836,9556,990,704
   Common Stock
240,000
480,000
480,000
480,000
720,000
1,440,000
1,440,000
1,440,000
1,439,846
1,439,786
1,438,690
1,425,423
1,422,247
1,422,2471,425,4231,438,6901,439,7861,439,8461,440,0001,440,0001,440,000720,000480,000480,000480,000240,000
   Retained Earnings 
1,715,424
2,491,033
3,378,161
4,271,856
5,515,283
5,980,554
6,366,073
6,914,457
7,826,496
8,447,961
8,675,160
9,327,669
10,438,591
10,438,5919,327,6698,675,1608,447,9617,826,4966,914,4576,366,0735,980,5545,515,2834,271,8563,378,1612,491,0331,715,424
   Capital Surplus 0000000000000
   Treasury Stock00000-83,895-51,619000000
   Other Stockholders Equity 
0
0
0
0
0
-35,453
98,451
371
87,822
131,108
-3,507
-77,486
459,824
459,824-77,486-3,507131,10887,82237198,451-35,45300000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,715,734
Cost of Revenue-9,980,682
Gross Profit10,735,05210,735,052
 
Operating Income (+$)
Gross Profit10,735,052
Operating Expense-17,611,917
Operating Income3,103,817-6,876,865
 
Operating Expense (+$)
Research Development2,256,376
Selling General Administrative4,703,239
Selling And Marketing Expenses-
Operating Expense17,611,9176,959,615
 
Net Interest Income (+$)
Interest Income2,420
Interest Expense-423,183
Other Finance Cost-127,764
Net Interest Income-292,999
 
Pretax Income (+$)
Operating Income3,103,817
Net Interest Income-292,999
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,866,8993,103,817
EBIT - interestExpense = -423,183
2,266,617
2,689,800
Interest Expense423,183
Earnings Before Interest and Taxes (EBIT)-3,290,082
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax2,866,899
Tax Provision-474,665
Net Income From Continuing Ops2,392,2342,392,234
Net Income2,266,617
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net-292,999
 

Technical Analysis of Kelun
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Kelun. The general trend of Kelun is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Kelun's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Sichuan Kelun Pharmaceutical Co Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 33.28.

The bearish price targets are: 31.18 > 30.89 > 30.83.

Tweet this
Sichuan Kelun Pharmaceutical Co Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Sichuan Kelun Pharmaceutical Co Ltd. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Sichuan Kelun Pharmaceutical Co Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Sichuan Kelun Pharmaceutical Co Ltd. The current macd is 0.55121443.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kelun price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Kelun. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Kelun price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Sichuan Kelun Pharmaceutical Co Ltd. The current adx is 25.89.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Kelun shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Sichuan Kelun Pharmaceutical Co Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Sichuan Kelun Pharmaceutical Co Ltd. The current sar is 29.06.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Sichuan Kelun Pharmaceutical Co Ltd. The current rsi is 69.05. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Sichuan Kelun Pharmaceutical Co Ltd. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Kelun price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Stochastic Oscillator ChartSichuan Kelun Pharmaceutical Co Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Sichuan Kelun Pharmaceutical Co Ltd. The current cci is 324.44.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Sichuan Kelun Pharmaceutical Co Ltd. The current cmo is 48.77.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Sichuan Kelun Pharmaceutical Co Ltd. The current willr is -4.61956522.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Williams %R ChartSichuan Kelun Pharmaceutical Co Ltd Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Sichuan Kelun Pharmaceutical Co Ltd.

Sichuan Kelun Pharmaceutical Co Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Sichuan Kelun Pharmaceutical Co Ltd. The current atr is 1.05731879.

Sichuan Kelun Pharmaceutical Co Ltd Daily Average True Range (ATR) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Sichuan Kelun Pharmaceutical Co Ltd. The current obv is 239,221,832.

Sichuan Kelun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) ChartSichuan Kelun Pharmaceutical Co Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Sichuan Kelun Pharmaceutical Co Ltd. The current mfi is 64.89.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Sichuan Kelun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) ChartSichuan Kelun Pharmaceutical Co Ltd Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Sichuan Kelun Pharmaceutical Co Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-12-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-19RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-25MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-26ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

Sichuan Kelun Pharmaceutical Co Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Sichuan Kelun Pharmaceutical Co Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5069.045
Ma 20Greater thanMa 5030.066
Ma 50Greater thanMa 10028.850
Ma 100Greater thanMa 20027.948
OpenGreater thanClose31.210
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Kelun with someone you think should read this too:
  • Are you bullish or bearish on Kelun? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Kelun? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Sichuan Kelun Pharmaceutical Co Ltd

I send you an email if I find something interesting about Sichuan Kelun Pharmaceutical Co Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Sichuan Kelun Pharmaceutical Co Ltd.

Receive notifications about Sichuan Kelun Pharmaceutical Co Ltd in your mailbox!